DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13185
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMahesh, R.-
dc.date.accessioned2023-11-20T09:08:12Z-
dc.date.available2023-11-20T09:08:12Z-
dc.date.issued2013-11-
dc.identifier.urihttps://academic.oup.com/jpp/article/66/1/122/6128065-
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13185-
dc.description.abstractThe inconsistent therapeutic outcome necessitates identifying novel compounds for the treatment of depression. Therefore, the present study is aimed at evaluating the antidepressant-like effects of a novel 5-HT3 receptor antagonist 3-methoxy-N-p-tolylquinoxalin-2-carboxamide (QCM-4) on chronic unpredictable mild stress (CUMS) induced behavioral and biochemical alterations in mice.en_US
dc.language.isoenen_US
dc.publisherOxforden_US
dc.subjectPharmacyen_US
dc.subject5-HT3 antagonisten_US
dc.subjectChronic unpredictable mild stress (CUMS)en_US
dc.subjectImmobility timeen_US
dc.subjectLipid peroxidationen_US
dc.subjectSucroseen_US
dc.titleQCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino miceen_US
dc.typeArticleen_US
Appears in Collections:Department of Pharmacy

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.